Skip to main content

Table 4 Patient Demographics and Baseline Characteristics (Prev-AP cohorts)

From: Prevalence of metabolic syndrome in patients with schizophrenia, and metabolic changes after 3 months of treatment with antipsychotics - results from a German observational study

Prev-AP*, FAS

 

Age (years)

BMI (kg/m²)

Waist (cm)

SBP (mm/Hg)

DBP (mm/Hg)

CGI-S score

 

Male

Smokers

Prev-Olz

Mean

42.9

28.9

103.4

131.1

83.6

3.5

N

36

26

(N = 62)

SD

13.9

5.2

17.1

18.0

8.2

1.2

%

58.1

41.9

Prev-Risp

Mean

46.0

28.9

103.4

128.2

83.1

4.1

N

38

30

(N = 67)

SD

13.2

6.2

17.3

12.7

7.4

1.2

%

56.7

44.8

Prev-Quet

Mean

46.2

27.0

100.0

125.9

81.7

3.9

N

24

17

(N = 49)

SD

12.1

4.9

18.2

13.5

8.5

1.2

%

49.0

34.7

Prev-Atyp

Mean

46.7

28.4

101.1

128.1

81.9

4.0

N

50

43

(N = 103)

SD

13.2

5.8

17.2

16.7

9.9

1.2

%

48.5

41.8

Prev-Typ

Mean

49.1

28.4

102.1

129.3

84.0

4.0

N

42

43

(N = 90)

SD

11.9

5.9

18.7

15.9

9.7

1.2

%

46.7

47.8

Prev-Com

Mean

44.5

29.3

103.3

127.0

82.3

3.6

N

58

43

(N = 109)

SD

11.6

5.4

14.7

11.3

8.9

1.2

%

53.2

39.5

Prev-None

Mean

43.0

25.3

91.3

125.0

80.2

4.2

N

69

61

(N = 162)

SD

14.7

4.5

15.1

15.7

9.3

1.0

%

42.6

37.7

Total FAS

Mean

45.2

27.8

99.5

127.4

82.1

3.9

N

317

263

(N = 642)

SD

13.3

5.6

17.2

15.1

9.1

1.2

%

49.4

41.0

  1. Abbreviations: BMI = body mass index; CGI-S = clinical global impression - severity scale; DBP = diastolic blood pressure; FAS = full analysis set; Prev-AP = previous antipsychotic treatment cohort; SBP = systolic blood pressure; SD = standard deviation, Waist = waist circumference
  2. Missing values: BMI 1 (Prev-Comb), waist circumference 1 (Prev-Comb), SBP and DBP 1 (Prev-Risp)
  3. * The time period through which the previous antipsychotic medication had been taken ranged from less than a month up to more than a decade.